Synaptosomal-Associated Protein, 25kDa (SNAP-25) is a Target Soluble NSF (N-ethylmaleimide-sensitive factor) Attachment Protein Receptor (t-SNARE) protein encoded by the SNAP25 gene found on chromosome 20p12.2 in humans.[1] [2] SNAP-25 is a component of the trans-SNARE complex, which accounts for membrane fusion specificity, directly executing fusion by forming a tight complex that brings the synaptic vesicle and plasma membranes together.[3]
Structure and function edit
SNAP-25, a Q-SNARE protein, is anchored to the cytosolic face of membranes via palmitoyl side chains covalently bound to cysteine amino acid residues found in the central linker domain of the molecule. This means that SNAP-25 does not contain a trans-membrane domain.[5]
SNAP-25 has been identified to contribute two α-helices to the SNARE complex, a four-α-helix domain complex.[6] The SNARE complex participates in vesicular fusion, which involves the docking, priming and merging of a vesicle with the cell membrane to initiate an exocytotic event. Synaptobrevin, a protein that is a part of the vesicle-associated membrane protein (VAMP) family, and syntaxin-1 also help form the SNARE complex by each contributing a single α-helix. SNAP-25 assembles with synaptobrevin and syntaxin-1, and the selective binding of these proteins enables vesicle docking and fusion to occur at active zones on the plasma membrane.[7] The energy needed for fusion to occur, results from the assembly of the SNARE proteins along with additional Sec1/Munc18-like (SM) proteins.[8]
To form the SNARE complex, synaptobrevin, syntaxin-1, and SNAP-25 associate and begin to wrap around each other forming a coiled coil quaternary structure. The α-helices of both synaptobrevin and syntaxin-1 bind to those of SNAP-25. Synaptobrevin binds the α-helix near the C-terminus of SNAP-25, while syntaxin-1 binds the α-helix near the N-terminus.[5] Dissociation of the SNARE complex is driven by ATPase N-ethylmaleimide-sensitive fusion (NSF) protein.[8]
SNAP-25 inhibits presynaptic P-, Q-, and L-type voltage-gated calcium channels [9] and interacts with the synaptotagmin C2B domain in Ca2+-independent fashion.[10] In glutamatergic synapses, SNAP-25 decreases the Ca2+responsiveness, while it is normally absent in GABAergic synapses.[11]
Two isoforms (mRNA splice variants) of SNAP-25 exist, which are SNAP-25a and SNAP25b. The two isoforms differ by 9 amino acid residues, including a re-localization of one of the four palmitoylated cysteine residues involved in membrane attachment.[12] The major characteristics of these two forms are outlined in the table below.
| SNAP25a | SNAP25b | |
|---|---|---|
| Structure | N-terminal α-helix
Coil linker region with four cysteines clustered towards the center C-terminal α-helix |
N-terminal α-helix
Coil linker region with four cysteines clustered towards the C-terminus C-terminal α-helix |
| Expression | Major SNAP-25 isoform in embryos and developing neural tissue
Minimal expression in adult tissue except in pituitary and adrenal gland tissues |
Minimal expression during development, major isoform in adult neuronal tissue[13] |
| Localization | Diffuse | Localized to terminals and varicosities[13] |
SNAP-25 not only plays a role in synaptogenesis and the exocytotic release of neurotransmitters, but it also affects spine morphogenesis and density, post synaptic receptor trafficking and neuronal plasticity. Other non-neuronal processes such as metabolism can also be affected by SNAP-25 protein expression.[14][15]
Clinical significance edit
Attention Deficit Hyperactivity Disorder (ADHD) edit
Consistent with the regulation of synaptic Ca2+ responsiveness, heterozygous deletion of the SNAP-25 gene in mice results in a hyperactive phenotype similar to attention deficit hyperactivity disorder (ADHD). In heterozygous mice, a decrease in hyperactivity is observed with dextroamphetamine (or Dexedrine), an active ingredient in the ADHD drug Adderall. Homozygous deletions of the SNAP-25 gene are lethal. An additional study indicated that incorporation of a SNAP-25 transgene back into the heterozygous SNAP-25 mutant mouse can rescue normal activity levels bringing them back to levels similar to wildtype mice. This suggests that low protein levels of SNAP-25 can be a cause of hyper-kinetic behavior.[16] Subsequent studies have suggested that at least some of the SNAP-25 gene mutations in humans might predispose to ADHD.[17][18] Identification of polymorphisms in the 3’ untranslated region of the SNAP-25 gene was established in linkage studies with families that had been pre-diagnosed ADHD.[19]
Schizophrenia edit
Studies in the post mortem brains of patients with Schizophrenia have shown that altered protein levels of SNAP-25 are specific to regions of the brain. Reduced SNAP-25 protein expression has been observed in the hippocampus as well as an area of the frontal lobe known as Broadman’s area 10, whereas SNAP-25 expression has increased in both the cingulate cortex and prefrontal lobe of Broadman’s area 9. The varying levels of SNAP-25 protein found in different areas of the brain have been thought to contribute to the conflicting psychological behaviors (depressive vs. hyperactive) expressed in some Schizophrenic patients.[20][21][22][23]
The blind-drunk (Bdr) mouse model which has a point mutation in the SNAP-25b protein has provided a complex phenotype involving behaviors such as an abnormal circadian rhythm,[24] uncoordinated gait, and disinterest in new objects/toys.[25] Another mouse model generated from Cre-LoxP recombination, showed that conditional knockout (cKO) of the SNAP-25 gene in the forebrain, showed inactive SNAP-25 gene expression in glutamatergic neurons. However, significant glutamate levels were found in the cortex of these cKO mice. [26] These mice also exhibited deficient social skills, impaired learning and memory, enhanced kinesthetic activity, a reduced startle response, impaired self-care, nursing ability and nest-building skills. Antipsychotic drugs such as Clozapine and Riluzole have been shown to significantly reduce the schizophrenic phenotype expressed in SNAP-25 cKO mice.[26]
Alzheimer's Disease edit
Individuals with Alzhiemer’s disease have been shown to have decreased presynaptic protein levels and impaired synaptic function in neurons. SNAP-25 can be used as a biomarker in the cerebral spinal fluid (CSF) of patients exhibiting different variations of Alzheimer's disease (prodromal Alzheimer’s and overt Alzheimer’s). Increased levels of SNAP-25 protein were observed in patients with Alzheimer’s compared to control individuals. Additionally, the presence of truncated SNAP-25 protein can be seen in the CSF of some patients with this disease.[27] In five distinct regions of the brain, low levels of SNAP-25 can be seen in patients with Alzheimer’s.[28]
Bipolar Disorder edit
A single nucleotide polymorphism in the SNAP-25 gene promoter has been shown to influence the expression levels of the SNAP-25b isoform in the prefrontal cortex. Increased levels of SNAP-25b have been shown to impair synaptic transmission and maturation which could lead to early-onset bipolar disorder (EOBD).The most abundant isoform of SNAP-25 is SNAP-25a during the early weeks of development in mice however in adulthood there is a change and the SNAP-25b isoform increases in the brain. This is shown to correlate with adolescent humans being increasingly diagnosed with EOBD during puberty.[29] It has been suggested that early-onset bipolar disorder is more closely linked to Schizophrenia than to Bipolar Disorder itself. The single nucleotide polymorphism of SNAP-25 (rs6039769) associated with EOBD has been shown to increase the risk of patients developing Schizophrenia.[14]
Botulism edit
A genome wide association study pointed to the rs362584 polymorphism in the gene being possibly associated with the personality trait neuroticism.[30] Botulinum toxins A, C and E cleave SNAP-25,[31] leading to paralysis in clinically developed botulism.
Epilepsy edit
Deletion of the SNAP-25b isoform has been shown to cause developmental abnormalities and seizures in mice. High levels of SNAP-25a and the protein syntaxin appear to be linked to seizures found in infantile-epilepsy. SNAP-25 knock-in mice have distinct phenotypic behavior similar to the fits and seizures of epileptic patients, as well as anxiety.[32]
Learning Disabilities edit
In the coloboma hyperactive mutant mouse model where SNAP-25 protein levels are reduced to 50% of the normal level, depolarized neurotransmitter release of dopamine and serotonin were reduced as well as glutamate release. The reduction in glutamate levels can lead to deficient memory and increased learning disabilities.[33] Certain polymorphisms of SNAP-25 (rs363043, rs353016, rs363039, rs363050) affect the cognitive behavior, specifically the Intelligence Quotient (IQ)), of patients without pre-existing neurological diseases.[34]
Neonatal Development edit
SNAP-25 protein expression can be altered by sex hormone levels in neonatal rats. Male rats that received an antiestrogen drug showed a 30% decrease in SNAP-25 levels and females treated with estrogen or testosterone showed a 30% increase in SNAP-25 levels.[35] This suggests that synaptosomal proteins, such as SNAP-25, may have a dependence on neonatal hormone levels during brain development in rats. An additional study, showed that SNAP-25 levels in the hippocampus of the brain in neonatal mice were altered if the mother had been exposed to human influenza virus during pregnancy. [36]
Interactive pathway map edit
Click on genes, proteins and metabolites below to link to respective articles.[§ 1]
- ^ The interactive pathway map can be edited at WikiPathways: "NicotineDopaminergic_WP1602".
References edit
- ^ Maglott DR, Feldblyum TV, Durkin AS, Nierman WC (May 1996). "Radiation hybrid mapping of SNAP, PCSK2, and THBD (human chromosome 20p)". Mamm. Genome. 7 (5): 400–1. doi:10.1007/s003359900120. PMID 8661740. S2CID 34951074.
- ^ Najera, Katherine; Fagan, B. Matthew; Thompson, Peter M. (2019). "SNAP-25 in Major Psychiatric Disorders: A Review". Neuroscience. 420: 79–85. doi:10.1016/j.neuroscience.2019.02.008. PMID 30790667. S2CID 73486873.
- ^ Rizo J, Südhof TC (2002). "Snares and Munc18 in synaptic vesicle fusion". Nat Rev Neurosci. 3 (8): 641–653. doi:10.1038/nrn898. PMID 12154365. S2CID 13351502.
- ^ Georgiev, Danko D; James F . Glazebrook (2007). "Subneuronal processing of information by solitary waves and stochastic processes". In Lyshevski, Sergey Edward (ed.). Nano and Molecular Electronics Handbook. Nano and Microengineering Series. CRC Press. pp. 17–1–17–41. doi:10.1201/9781420008142.ch17 (inactive 2022-06-26). ISBN 978-0-8493-8528-5.
{{cite book}}: CS1 maint: DOI inactive as of June 2022 (link) - ^ a b Chapman ER, An S, Barton N, Jahn R (1994). "SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils". J. Biol. Chem. 269 (44): 27427–32. doi:10.1016/S0021-9258(18)47003-2. PMID 7961655.
- ^ Pevsner J, Hsu SC, Braun JE, Calakos N, Ting AE, Bennett MK, Scheller RH (1994). "Specificity and regulation of a synaptic vesicle docking complex". Neuron. 13 (2): 353–61. doi:10.1016/0896-6273(94)90352-2. PMID 8060616. S2CID 46713725.
- ^ Calakos N, Bennett MK, Peterson KE, Scheller RH (1994). "Protein-protein interactions contributing to the specificity of intracellular vesicular trafficking". Science. 263 (5150): 1146–9. Bibcode:1994Sci...263.1146C. doi:10.1126/science.8108733. PMID 8108733.
- ^ a b Sudhof, T. C.; Rizo, J. (2011-12-01). "Synaptic Vesicle Exocytosis". Cold Spring Harbor Perspectives in Biology. 3 (12): a005637. doi:10.1101/cshperspect.a005637. ISSN 1943-0264. PMC 3225952. PMID 22026965.
- ^ Hodel A (October 1998). "SNAP-25". Int. J. Biochem. Cell Biol. 30 (10): 1069–73. doi:10.1016/S1357-2725(98)00079-X. PMID 9785471.
- ^ Chapman ER (July 2002). "Synaptotagmin: a Ca(2+) sensor that triggers exocytosis?" (PDF). Nat. Rev. Mol. Cell Biol. 3 (7): 498–508. doi:10.1038/nrm855. PMID 12094216. S2CID 12384262. Archived from the original (PDF) on August 29, 2006.
- ^ Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S, Proux-Gillardeaux V, Galli T, Rossetto O, Frassoni C, Matteoli M (February 2004). "SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization". Neuron. 41 (4): 599–610. doi:10.1016/S0896-6273(04)00077-7. PMID 14980208. S2CID 16171280.
- ^ Nagy G, Milosevic I, Fasshauer D, Müller EM, de Groot BL, Lang T, Wilson MC, Sørensen JB (December 2005). "Alternative splicing of SNAP-25 regulates secretion through nonconservative substitutions in the SNARE domain". Mol. Biol. Cell. 16 (12): 5675–85. doi:10.1091/mbc.E05-07-0595. PMC 1289412. PMID 16195346.
- ^ a b Bark, Christina (February 1995). "Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development". Proceedings of the National Academy of Sciences. 92 (5): 1510–1514. Bibcode:1995PNAS...92.1510B. doi:10.1073/pnas.92.5.1510. PMC 42549. PMID 7878010.
- ^ a b Houenou, Josselin; Boisgontier, Jennifer; Henrion, Annabelle; d'Albis, Marc-Antoine; Dumaine, Anne; Linke, Julia; Wessa, Michèle; Daban, Claire; Hamdani, Nora; Delavest, Marine; Llorca, Pierre-Michel (2017-10-25). "A Multilevel Functional Study of a SNAP25 At-Risk Variant for Bipolar Disorder and Schizophrenia". Journal of Neuroscience. 37 (43): 10389–10397. doi:10.1523/JNEUROSCI.1040-17.2017. ISSN 0270-6474. PMC 6596626. PMID 28972123.
- ^ Antonucci, Flavia; Corradini, Irene; Fossati, Giuliana; Tomasoni, Romana; Menna, Elisabetta; Matteoli, Michela (2016). "SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic Functions". Frontiers in Synaptic Neuroscience. 8: 7. doi:10.3389/fnsyn.2016.00007. ISSN 1663-3563. PMC 4805587. PMID 27047369.
- ^ Steffensen, Scott C.; Henriksen, Steven J.; Wilson, Michael C. (1999). "Transgenic rescue of SNAP-25 restores dopamine-modulated synaptic transmission in the coloboma mutant". Brain Research. 847 (2): 186–195. doi:10.1016/S0006-8993(99)02023-5. PMID 10575087. S2CID 41368865.
- ^ Brophy K, Hawi Z, Kirley A, Fitzgerald M, Gill M (2002). "Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): evidence of linkage and association in the Irish population". Mol. Psychiatry. 7 (8): 913–7. doi:10.1038/sj.mp.4001092. hdl:2262/36350. PMID 12232787.
- ^ Mill J, Curran S, Kent L, Gould A, Huckett L, Richards S, Taylor E, Asherson P (April 2002). "Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder". Am. J. Med. Genet. 114 (3): 269–71. doi:10.1002/ajmg.10253. PMID 11920846.
- ^ Barr, C L; Feng, Y; Wigg, K; Bloom, S; Roberts, W; Malone, M; Schachar, R; Tannock, R; Kennedy, J L (2000). "Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder". Molecular Psychiatry. 5 (4): 405–409. doi:10.1038/sj.mp.4000733. ISSN 1359-4184. PMID 10889551. S2CID 22779309.
- ^ Corradini, Irene; Verderio, Claudia; Sala, Mariaelvina; Wilson, Michael C.; Matteoli, Michela (2009). "SNAP-25 in Neuropsychiatric Disorders". Annals of the New York Academy of Sciences. 1152 (1): 93–99. doi:10.1111/j.1749-6632.2008.03995.x. PMC 2706123. PMID 19161380.
- ^ Gabriel, Steven M. (1997-06-01). "Increased Concentrations of Presynaptic Proteins in the Cingulate Cortex of Subjects With Schizophrenia". Archives of General Psychiatry. 54 (6): 559–566. doi:10.1001/archpsyc.1997.01830180077010. ISSN 0003-990X. PMID 9193197.
- ^ Thompson, Peter M.; Sower, Angela C.; Perrone-Bizzozero, Nora I. (1998). "Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia". Biological Psychiatry. 43 (4): 239–243. doi:10.1016/S0006-3223(97)00204-7. PMID 9513732. S2CID 20347660.
- ^ Thompson, Peter M.; Egbufoama, Shirley; Vawter, Marquis P. (2003). "SNAP-25 reduction in the hippocampus of patients with schizophrenia". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27 (3): 411–417. doi:10.1016/S0278-5846(03)00027-7. PMID 12691775. S2CID 1051797.
- ^ Oliver, Peter; Sobczyk, Melanie; Maywood, Elizabeth; Edwards, Benjamin; Lee, Sheena; Livieratos, Achilleas; Oster, Henrik; Butler, Rachel; Godinho, Sofia; Wulff, Katharina; Peirson, Stuart (2012). "Disrupted Circadian Rhythms in a Mouse Model of Schizophrenia". Current Biology. 22 (4): 314–319. doi:10.1016/j.cub.2011.12.051. PMC 3356578. PMID 22264613.
- ^ Jeans, Alexander F.; Oliver, Peter L.; Johnson, Reuben; Capogna, Marco; Vikman, Jenny; Molnár, Zoltán; Babbs, Arran; Partridge, Christopher J.; Salehi, Albert; Bengtsson, Martin; Eliasson, Lena (2007-02-13). "A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse". Proceedings of the National Academy of Sciences. 104 (7): 2431–2436. doi:10.1073/pnas.0610222104. ISSN 0027-8424. PMC 1793901. PMID 17283335.
- ^ a b Yang, Hua; Zhang, Mengjie; Shi, Jiahao; Zhou, Yunhe; Wan, Zhipeng; Wang, Yicheng; Wan, Yinghan; Li, Jun; Wang, Zhugang (2017-11-28). "Brain-Specific SNAP-25 Deletion Leads to Elevated Extracellular Glutamate Level and Schizophrenia-Like Behavior in Mice". Neural Plasticity. 2017: 1–11. doi:10.1155/2017/4526417. PMC 5727794. PMID 29318050.
- ^ Brinkmalm, Ann; Brinkmalm, Gunnar; Honer, William G; Frölich, Lutz; Hausner, Lucrezia; Minthon, Lennart; Hansson, Oskar; Wallin, Anders; Zetterberg, Henrik; Blennow, Kaj; Öhrfelt, Annika (2014). "SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease". Molecular Neurodegeneration. 9 (1): 53. doi:10.1186/1750-1326-9-53. ISSN 1750-1326. PMC 4253625. PMID 25418885.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Greber, Susi; Lubec, Gert; Cairns, Nigel; Fountoulakis, Michael (1999). "Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease". Electrophoresis. 20 (4–5): 928–934. doi:10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z. ISSN 1522-2683. PMID 10344268. S2CID 22531212.
- ^ Etain, B; Dumaine, A; Mathieu, F; Chevalier, F; Henry, C; Kahn, J-P; Deshommes, J; Bellivier, F; Leboyer, M; Jamain, S (2010). "A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain". Molecular Psychiatry. 15 (7): 748–755. doi:10.1038/mp.2008.148. ISSN 1359-4184. PMC 2937032. PMID 19125158.
- ^ Terracciano A, Sanna S, Uda M, Deiana B, Usala G, Busonero F, Maschio A, Scally M, Patriciu N, Chen WM, Distel MA, Slagboom EP, Boomsma DI, Villafuerte S, Sliwerska E, Burmeister M, Amin N, Janssens AC, van Duijn CM, Schlessinger D, Abecasis GR, Costa PT (October 2008). "Genome-wide association scan for five major dimensions of personality". Mol. Psychiatry. 15 (6): 647–56. doi:10.1038/mp.2008.113. PMC 2874623. PMID 18957941.
- ^ Aoki KR, Guyer B (November 2001). "Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions". Eur. J. Neurol. 8 Suppl 5: 21–9. doi:10.1046/j.1468-1331.2001.00035.x. PMID 11851731. S2CID 36829902.
- ^ Rohena, Luis; Neidich, Julie; Truitt Cho, Megan; Gonzalez, Kelly DF; Tang, Sha; Devinsky, Orrin; Chung, Wendy K (2013). "Mutation in SNAP25 as a novel genetic cause of epilepsy and intellectual disability". Rare Diseases. 1 (1): e26314. doi:10.4161/rdis.26314. ISSN 2167-5511. PMC 3932847. PMID 25003006.
- ^ Raber, Jacob; Mehta, Prashant P.; Kreifeldt, Max; Parsons, Loren H.; Weiss, Friebert; Bloom, Floyd E.; Wilson, Michael C. (2002-11-18). "Coloboma Hyperactive Mutant Mice Exhibit Regional and Transmitter-Specific Deficits in Neurotransmission". Journal of Neurochemistry. 68 (1): 176–186. doi:10.1046/j.1471-4159.1997.68010176.x. PMID 8978724. S2CID 25505619.
- ^ Gosso, M F; de Geus, E J C; van Belzen, M J; Polderman, T J C; Heutink, P; Boomsma, D I; Posthuma, D (2006). "The SNAP-25 gene is associated with cognitive ability: evidence from a family-based study in two independent Dutch cohorts". Molecular Psychiatry. 11 (9): 878–886. doi:10.1038/sj.mp.4001868. ISSN 1359-4184. PMID 16801949. S2CID 437158.
- ^ Lustig, Robert H.; Hua, Ping; Wilson, Michael C.; Federoff, Howard J. (1993). "Ontogeny, sex dimorphism, and neonatal sex hormone determination of synapse-associated messenger RNAs in rat brain". Molecular Brain Research. 20 (1–2): 101–110. doi:10.1016/0169-328X(93)90114-5. PMID 8255171.
- ^ Fatemi, S.Hossein; Sidwell, Robert; Kist, David; Akhter, Pervez; Meltzer, Herbert Y; Bailey, Kevin; Thuras, Paul; Sedgwick, Jerry (1998). "Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero". Brain Research. 800 (1): 1–9. doi:10.1016/S0006-8993(98)00450-8. PMID 9685568. S2CID 36917316.